Tobramycin (Claris Lifesciences Inc.)
Welcome to the PulseAid listing for the Tobramycin drug offered from Claris Lifesciences Inc.. This Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Claris Lifesciences Inc. |
NON-PROPRIETARY NAME: | Tobramycin |
SUBSTANCE NAME: | TOBRAMYCIN SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-07-15 |
END MARKETING DATE: | 0000-00-00 |
Tobramycin HUMAN PRESCRIPTION DRUG Details:
Item Description | Tobramycin from Claris Lifesciences Inc. |
LABELER NAME: | Claris Lifesciences Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(mg/mL) |
START MARKETING DATE: | 2016-07-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 36000-242_6524618f-c24e-4827-a07c-86e5bdc25078 |
PRODUCT NDC: | 36000-242 |
APPLICATION NUMBER: | ANDA206965 |
Other TOBRAMYCIN SULFATE Pharmaceutical Manufacturers / Labelers: